Treatment with PD‐L1 siRNA and IL‐2 pDNA‐loaded TT‐LDCP NPs significantly suppressed the tumor growth and metastasis compared to that treated with TT‐LDCP loaded with control siRNA and HCC vaccine. This evidence concerns the gene CD274 and hepatocellular carcinoma.